Disease - Stage Please select 1. AML - 1st remission(OR=1.00) 2. AML - 2nd remission(OR=0.74) 3. AML - 3rd and higher CR and relapse(OR=0.34) 4. CML - CP1, dx to tx < 12 months(OR=1.92) 5. CMP - CP1, dx to tx >= 12 months(OR=1.35) 6. CML - Accelerated phase/CP2(OR=0.81) 7. CML - Blast phase(OR=0.40) 8 .ALL - 1st remission(OR=1.14) 9. ALL - 2st remission(OR=0.53) 10. ALL - 3rd and higher CR and relapse(OR=0.30) 11. Chronic lymphocytic leukemia(OR=1.14) 12. Other leukemia((OR=0.86) 13. MDS - RA/RARS/RCMD(OR=1.01) 14. MDS - RAEB/RAEB-IT(OR=0.66) 15. MDS - Other(OR=0.89) 16. Myeloproliferative disease(OR=0.94) 17. Non-Hodgkin lymphoma(OR=0.72) 18. Hodgkin lymphoma(OR=0.82) 19. Plasma cell disorders(OR=0.53) 20. Other malig9t disease(OR=0.19) 21. Severe aplastic anemia(OR=1.51) 22. Other non-malig9t(OR=1.18)

Recipient Age at Transplant Please select 23. 0 - 10 years(OR=1.00) 24. 11 - 17 years(OR=0.75) 25. 18 - 30 years(OR=0.71) 26. 31 - 40 years(OR=0.77) 27. 41 - 50 years*(OR=0.62) 28. 51 - 60 years(OR=0.55) 29. > 60 years(OR=0.46)

Donor Age at Transplant (PBSC and bone marrow only) Please select 30. 18 - 30 years(OR=1.00) 31. 31 - 45 years(OR=0.88) 32. 46+ years(OR=0.80)

Recipient CMV Status Please select 33. Negative(OR=1.00) 34. Positive(OR=0.83) 35. Unknown(OR=0.74)

Recipient Race Please select 36. Caucasian(OR=1.00) 37. African American(OR=0.76) 38. Asian / Pacific Islander(OR=0.87) 39. Hispanic(OR=1.02) 40. Other / Unknown(OR=0.81)

Graft Type, HLA Match Status Please select 41. PB or BM, 8/8 allele match*(OR=1.00) 42. PB or BM, 7/8 allele match(OR=0.66) 43. PB or BM, <= 6/8 allele match(OR=0.46) 44. PB or BM, well matched(OR=1.00) 45. PB or BM, partially matched(OR=0.63) 46. PB or BM, mismatched(OR=0.42) 47. CB, 6/6(OR=0.64) 48. CB, 5/6(OR=0.65) 49. CB, <= 4/6(OR=0.51) 50. Multiple cord(OR=0.61)

Karnofsky / Lansky at Transplant Please select 51. >= 90(OR=1.00) 52. < 90(OR=0.59) 53. Unknown(OR=0.89)

Prior Autologous Transplant Please select 54. No(OR=1.00) 55. Yes(OR=0.85)

Coexisting Disease Please select 56. Absent(OR=1.00) 57. Present(OR=0.78)

Sensitivity to Chemotherapy (NHL only) Please select Not applicable 58. Sensitive(OR=1.00) 59. Resistant(OR=0.47) 60. Unknown(OR=0.71)

Sensitivity to Chemotherapy (HL only) Please select Not applicable 61. Sensitive(OR=1.00) 62. Resistant(OR=0.61) 63. Unknown(OR=0.99)

Duration of CR1 (AML/ALL not in CR1 or PIF) Please select Not applicable 64. <= 6 months(OR=1.00) 65. 6 months to 1 year(OR=1.11) 66. > 1 year(OR=1.95) 67. Missing(OR=1.38)

Conditioning Regimen * (NHL, HL, PCD, and OMD only) Please select Not applicable 68. Myeloablative(OR=1.00) 69. RIC(OR=2.14) 70. NST(OR=1.66)

Year of Transplant Please select 71. 2003(OR=1.00) 72. 2004(OR=0.98) 73. 2005(OR=1.19) 74. 2006(OR=1.19) 75. 2007(OR=1.31) 76. after 2007(OR=1.31)

(An odds ratio greater than 1.00 denotes a higher one year survival probability.)
* Categories with an asterisk are those in which the missing group is imputed.

  ............................  

Result: ______________________________________________